Metastatic Malignant Neoplasm in the Spine clinical trials
18 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Spine Radiosurgery for Symptomatic Metastatic Neoplasms
- Proton SBRT for Spinal Metastasis
- Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
- Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
- Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC
- Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
- Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column
- Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone
- Definitive Radiation for High-Risk Spine Metastases
- A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis
- Spine Oncology Registry
- Risk Adapted Spinal Cord/Cauda Constraint Relaxation for High-risk Patients With Metastatic Epidural Spinal Cord Compression Undergoing Spine Stereotactic Radiosurgery
- Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease
- Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)
- Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases
- D20054;LITT for Spine Tumors
- Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease
- Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Metastatic Malignant Neoplasm in the Spine” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.